Development and validation of stability indicating method for estimation of buparvaquone by forced degradation studies

Shaikh Tanveer, Shelke Sushil, Katerina Lalatsa, Kakde Rajendra

Research output: Contribution to journalArticlepeer-review

17 Downloads (Pure)

Abstract

Aim: A lucid, rapid and precise stability-indicating method was developed by using HPLC for the estimation of Buparvaquone in bulk as well as pharmaceutical dosage form by forced degradation studies.

Materials and Methods: Princeton C18 column (4.6 × 150 mm, 5μ) and mobile phase containing 1% glacial acetic acid and acetonitrile in the proportion of 5:95 v/v was used throughout the study. The flow rate was 0.9 ml/m and the detecting wavelength was kept as 251 nm using the PDA detector.

Results: The retention time of Buparvaquone was found to be at 8.6 ± 0.5 m. The method developed was validated, as stated in ICH Q2 (R1) guidelines. It was found to be linear within concentration ranging from 2-20 μg/ml having a correlation coefficient 0.999 and other parameters are also under permissible limits.

Conclusion: Buparvaquone was exposed to different stress conditions like acidic, basic, neutral, thermal, peroxide and also photolytic. Amongst all, the drug was found to be more degraded under basic as well as peroxide conditions.
Original languageEnglish
Pages (from-to)790-797
Number of pages8
JournalIndian Journal of Pharmaceutical Education and Research
Volume54
Issue number3
DOIs
Publication statusPublished - 1 Aug 2020

Keywords

  • buparvaquone
  • forced degradation
  • validation
  • RP-HPLC
  • stability

Fingerprint

Dive into the research topics of 'Development and validation of stability indicating method for estimation of buparvaquone by forced degradation studies'. Together they form a unique fingerprint.

Cite this